Pasteur Institute of Iran Shares Details of Joint Vaccine Project with Cuba

  February 04, 2021   Read time 1 min
Pasteur Institute of Iran Shares Details of Joint Vaccine Project with Cuba
Head of Pasteur Institute of Iran Alireza Bigalri said that Tehran and Havana will start the third phase of double-blind clinical trial of their jointly developed COVID-19 vaccine in coming weeks.

Tehran, SAEDNEWS, Feb. 4: Biglari said on Wednesday that Iran and Cuba are going to begin the third phase of clinical test for the coronavirus vaccine that has been produced by both countries in the coming weeks.

“The vaccine is transported from Cuba to Iran, then Iran will test its quality, he noted, adding, “Then it will be possibly presented to people in June.”

“Then, two million doses of vaccine will be presented monthly,” Biglari went on to say.

In relevant remarks in January, Deputy Health Ministry Farid Najafi announced that the third phase of clinical trial of Iranian-Cuban COVID-19 vaccine might kick off by the end of current Iranian year (March 20).

“The third phase may jointly begin with participation of 30,000 to 40,000 individuals in Iran and Cuba,” Najafi said, adding, “The first and second phases of clinical trials have completed in Cuba, and the third one will jointly begin in both countries.”

“The indigenous Iranian vaccine is among the safest as it has been made from an inactivated virus,” the official noted.

As for the import of vaccine, he stressed that what matters is the effectiveness, safety and price of the vaccine.

Najafi highlighted his country’s century-long record in vaccine production and said that Iran and Indonesia are the only Muslim countries producing vaccines.

He said that some of the home-grown vaccines are exported to regional states (Source: Fars News).